Chi B Vu

This inventor holds 43 USPTO granted patents and 40 published patent applications, plus 1 CIPO patent and 14 EPO patents, primarily in Sirtuin Modulators. Top assignees: Catabasis Pharmaceuticals, Inc., Sirtris Pharmaceuticals, Inc., Glaxosmithkline LLC. Active years: 2003-2019.

USPTO Granted Patents = 43 (Patent Applications = 40)

% Patents Active = 9.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 28)

Average Co-Inventor Count = 4.3

ph-index = 9

Forward Citations = 470(Granted Patents)

Location History:

Cambridge, MA (US) (2014)
Arlington, MA (US) (2003 - 2018)
Boston, MA (US) (2016 - 2019)

Company Filing History:

22 out of 29

Catabasis Pharmaceuticals, Inc.

patents

12 out of 14

Sirtris Pharmaceuticals, Inc.

7. 1 out of 834,350

Other

patents

Years Active: 2003-2019

Loading Chart...

Areas of Expertise:

Sirtuin Modulators

Fatty Acid Conjugates

Bicyclic Aza-Heterocycles

Fused Heterocyclic Compounds

Quinazolinone Analogues

Fatty Acid Derivatives

Niacin Conjugates

Salicylate Derivatives

Acylated Salicylates

Fatty Acid Fumarates

Lenalidomide Derivatives

Guanidine Derivatives

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10251845 - Fatty acid cysteamine conjugates and their use as activators of autophagy (2019-04-09),

2. 9957271 - Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators (2018-05-01),

3. RE46608 - Fatty acid niacin conjugates and their uses (2017-11-13),

4. RE46605 - Fatty acid niacin conjugates and their uses (2017-11-13),

5. 9708245 - Fatty acid acylated salicylates and their uses (2017-07-18),

6. 9556201 - Bicyclic pyridines and analogs as sirtuin modulators (2017-01-31),

7. 9486534 - Niacin conjugated fatty acid mixtures and their uses (2016-11-08),

8. 9326986 - Quinazolinone, quinolone and related analogs as sirtuin modulators (2016-05-03),

9. 9289503 - Fatty acid fumarate derivatives and their uses (2016-03-22),

10. 9278136 - Fatty acid niacin conjugates and their uses (2016-03-08),

11. 9238077 - Fatty acid niacin conjugates and their uses (2016-01-19),

12. 9216224 - Fatty acid COX inhibitor derivatives and their uses (2015-12-22),

13. 9150504 - Fatty acid guanidine and salicylate guanidine derivatives and their uses (2015-10-06),

14. 9085527 - Fatty acid acylated salicylates and their uses (2015-07-21),

15. 9084826 - Fatty acid conjugates of statin and FXR agonists; compositions and method of uses (2015-07-21),

Title: Chi B Vu: Pioneering Innovations in Biomedical Research

Introduction:

Chi B Vu, a visionary inventor based in Arlington, MA, is a true pioneer in the world of inventions. With a passion for innovation and a dedication to pushing the boundaries of what is possible, Vu's work continues to inspire the next generation of inventors and innovators.

Latest Patents:

Vu's latest patents showcase his groundbreaking contributions to the field of biomedical research. One of his inventions includes fatty acid cysteamine conjugates for the treatment of diseases involving dysregulation of autophagy. This compound shows promising potential in treating conditions such as cystic fibrosis, idiopathic pulmonary fibrosis, and neurodegenerative diseases.

Another notable patent by Vu involves substituted bicyclic aza-heterocycles as sirtuin modulators. These compounds have the ability to increase the lifespan of cells and treat various diseases related to aging, stress, diabetes, and cancer, among others.

Career Highlights:

Throughout his career, Chi B Vu has made significant strides in the biopharmaceutical industry. He has worked with esteemed companies such as Catabasis Pharmaceuticals, Inc. and Sirtris Pharmaceuticals, Inc., where his innovative research has paved the way for novel therapeutic interventions.

Collaborations:

Vu's collaborative spirit is evident in his work with colleagues such as Jean E Bemis and Jill C Milne. Together, they have contributed to groundbreaking discoveries in the field of biomedical sciences, setting new standards for excellence and innovation.

Conclusion:

In conclusion, Chi B Vu's passion for innovation and dedication to advancing the frontiers of science make him a trailblazer in the world of inventions. His inventive spirit and commitment to transformative research continue to shape the landscape of biopharmaceuticals, inspiring a new era of possibilities in healthcare and beyond.